Since many years, the antimicrobial resistance increases as well as for com
munity-acquired as for nosocomial infections. Antibiotic-resistant pneumoco
cci are neither more nor less virulent susceptible strains. Except for immu
nocompromised patients, the outcome of penicillin-resistant pneumococcal in
fections have been similar to those in patients who are infected by suscept
ible ones. Current levels of S. pneumoniae resistance to penicillin and cep
halosporin are not associated to an increase in mortality in children with
meningitis if adequate doses of antibiotics are given. Because empiric ther
apy has changed, antibiotic resistance has not been associated with increas
ed mortality. This statement can be extended to Meningococcus, for which 32
to 50 % of the strains have a decreased susceptibility to penicillin. For
nosocomial infections, S. aureus is the main studied pathogen. Several stud
ies report that in patients with severe diseases (bacteremia or pneumonia)
methicillin resistance of S. aureus had no significant impact on patient ou
tcome after adjustement for different confounders. The main risk factor for
mortality is the severe underlying diseases rather than the resistance as
well for methicillin -resistant S.aureus, as for vancomycin resistant enter
ococci, Klebsiella with extended spectrum beta lactamase and Enterobacters.
Recommendations for controlling epidemiologic surveillance, using barrier
precautions and limiting the use of antibiotics as well in the hospital as
in the community must be undertaken. (C) 2001 Editions scientifiques et med
icales Elsevier SAS.